C
Cerenome Inc D
D
CNSY
3.04000
USD
0.02
(0.66%)
مفتوح الان
حجم التداول
601
الربح لكل سهم
-3
العائد الربحي
-
P/E
1
حجم السوق
23,072,460
العنوان: Cerenome Inc
القطاع: الرعاية الصحية
الصناعة: Biotechnology
Cerenome Inc is a CNS oncology company advancing an integrated platform that combines precision diagnostics, targeted therapeutics, and artificial intelligence to improve outcomes for patients with central nervous system cancers. The Company's CNSide Diagnostics platform supports the detection, molecular characterization, and longitudinal monitoring of CNS cancers through cerebrospinal fluid-based testing. Its therapeutic platform, REYOBIQ (rhenium Re186 obisbemeda), is being evaluated in clinical trials for leptomeningeal metastases, recurrent glioblastoma, and pediatric brain cancers. The data & artificial intelligence platform is designed to integrate diagnostic, molecular, imaging, and clinical data into actionable insights that support precision oncology and therapeutic innovation.